This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Moxifloxacin vs. Polytrim for Conjunctivitis

Sponsored by University of Rochester

About this trial

Last updated 10 years ago

Study ID

RSRB #17454

Status

Completed

Type

Interventional

Phase

Phase 4

Placebo

No

Accepting

18-75 Years
1 to 18 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 13 years ago

What is this trial about?

The purpose of the study is to compare the effect of Polytrim Ophthalmic Solution and Moxifloxacin Ophthalmic Solution in treating your child's pink eye. Both these medications are approved by the Food and Drug Administration, for treatment of conjunctivitis. This study will investigate if both of the medications are equally good.

What are the participation requirements?

Yes

Inclusion Criteria

- 1 - 18 years of age with presumed bacterial conjunctivitis.

No

Exclusion Criteria

- Previous antibiotics or to receive systemic antibiotic.